Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dexmedetomidine on Brain Injury Patients
Sponsor: Damanhour University
Summary
The aim of the study is to check whether dexmedetomidine has neuroprotective properties in brain injury patients. The enrolled 60 patients will be divided into two groups; Group 1(n=30): are the patients who will receive dexmedetomidine. Group 2 (n=30): are the patients who represent the control group.
Official title: Effect of Dexmedetomidine on Brain Injury Patients
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-10-15
Completion Date
2025-10-28
Last Updated
2026-06-02
Healthy Volunteers
No
Conditions
Interventions
Dexmedetomidine Injectable Solution
Dexmedetomidine 200 mcg/ 2 mL IV.
Placebo
Normal Saline 2ml IV.
Locations (1)
Damanhour Teaching Hospital, General Organization for Teaching Hospitals and Institutes.
Damanhūr, Elbehairah, Egypt